valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darvas, Z; Falus, A; Pocza, P; Süli-Vargha, H | 1 |
| Gaetz, HP; Halpern, VJ; Karkowski, FJ; Nackman, GB; Tilson, MD | 2 |
| Tummalapalli, CM; Tyagi, SC | 1 |
4 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Chemokine CXCL12; Chemotaxis; Disease Progression; Elastin; Flow Cytometry; Galectin 3; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Melanoma; Neoplasm Invasiveness; Neovascularization, Pathologic; Oligopeptides; Polymerase Chain Reaction; Receptors, CXCR4; Skin Neoplasms; Tropoelastin; Vascular Endothelial Growth Factor C | 2008 |
Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model.
Topics: Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Elastin; Neovascularization, Pathologic; Oligopeptides; Rats; Rats, Wistar; Vasa Vasorum | 1996 |
Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model.
Topics: Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Elastin; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Oligopeptides; Rats; Rats, Wistar | 1997 |
Responses of vascular smooth muscle cell to extracellular matrix degradation.
Topics: Amino Acid Sequence; Chemotaxis; Collagen; Coronary Vessels; Elastin; Extracellular Matrix; Humans; In Vitro Techniques; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Oligopeptides; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Plasminogen Activator | 1999 |